Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Osteoarthritis Cartilage. 2022 Jan 11;30(4):559–569. doi: 10.1016/j.joca.2021.12.010

Table 3.

Knee Replacement Surgery over Five Years Among Participants Initiating Omeprazole, Pantoprazole, Lansoprazole, or Rabeprazole Compared with Initiation of Esomeprazole

Omeprazole vs. Esomeprazole Pantoprazole vs. Esomeprazole Lansoprazole vs. Esomeprazole Rabeprazole vs. Esomeprazole
Participant (n) 699 699 1,006 1,006 862 862 657 657
KR case (n) 90 60 114 85 84 71 72 58
Mean follow-up (year) 3.58 3.39 3.45 3.49 3.44 3.55 3.98 3.98
Rate (/1000 person-years) 37.1 23.7 32.8 24.2 28.3 23.2 27.6 22.2
HR, (95% CI) # * 1.57 1.00 1.37 1.00 1.20 1.00 1.24 1.00
(1.13, 2.17) (reference) (1.03, 1.81) (reference) (0.88, 1.65) (reference) (0.88, 1.75) (reference)

n, number; KR, knee replacement; HR, Hazard Ratio; CI, confidence interval; PS, propensity score; PPI, proton pump inhibitor; H2RA, Histamine-2 receptor antagonist.

#

Results from propensity score matched cohort study (i.e., intent-to-treat approach).

*

Adjusting for competing risk of death.